TRIAMCINOLONE DIACETATE: 30 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
30
Total FAERS Reports
0
Deaths Reported
10
Hospitalizations
30
As Primary/Secondary Suspect
7
Life-Threatening
3
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available
FDA Application: 011685 ·
First Report: 20100901 · Latest Report: 20240801
What Are the Most Common TRIAMCINOLONE DIACETATE Side Effects?
#1 Most Reported
Drug ineffective
14 reports (46.7%)
#2 Most Reported
Nausea
11 reports (36.7%)
#3 Most Reported
Off label use
9 reports (30.0%)
All TRIAMCINOLONE DIACETATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 14 | 46.7% | 0 | 2 |
| Nausea | 11 | 36.7% | 0 | 4 |
| Erythema | 9 | 30.0% | 0 | 7 |
| Off label use | 9 | 30.0% | 0 | 2 |
| Hyperhidrosis | 8 | 26.7% | 0 | 0 |
| Nephrolithiasis | 7 | 23.3% | 0 | 0 |
| Nightmare | 7 | 23.3% | 0 | 0 |
| Product use in unapproved indication | 7 | 23.3% | 0 | 0 |
| Sedation | 7 | 23.3% | 0 | 0 |
| Condition aggravated | 6 | 20.0% | 0 | 2 |
| Pain | 6 | 20.0% | 0 | 2 |
| Depression | 5 | 16.7% | 0 | 4 |
| Insomnia | 5 | 16.7% | 0 | 4 |
| Pruritus | 5 | 16.7% | 0 | 4 |
| Skin burning sensation | 5 | 16.7% | 0 | 4 |
| Skin exfoliation | 5 | 16.7% | 0 | 3 |
Who Reports TRIAMCINOLONE DIACETATE Side Effects? Age & Gender Data
Gender: 59.3% female, 40.7% male. Average age: 49.0 years. Most reports from: CA. View detailed demographics →
Is TRIAMCINOLONE DIACETATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 1 | 0 | 0 |
| 2016 | 1 | 0 | 0 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 0 |
| 2022 | 3 | 0 | 2 |
| 2024 | 2 | 0 | 0 |
What Is TRIAMCINOLONE DIACETATE Used For?
| Indication | Reports |
|---|---|
| Migraine | 7 |
| Product used for unknown indication | 5 |
Official FDA Label for TRIAMCINOLONE DIACETATE
Official prescribing information from the FDA-approved drug label.